Upcoming

Fusion CX Limited IPO

FUSIONCX · Mainboard · 14–16 Oct 2026

ShareDownload cardWhatsApp
PRICE BAND₹275–₹289
GMP* · 5.54%₹55Updated 12-Oct 18:02
SUBSCRIPTION—
ISSUE VALUE₹738 Cr
MARKETFRAME SCORE53/100Neutral
Low confidence20% input coverage

Half market demand (GMP, subscription, institutional bids), half offer-document data (valuation, profit trend, fresh issue vs OFS, debt, promoters, sector). Missing inputs are left out, not guessed. Not an apply/avoid recommendation.

Unofficial GMP premium5.54%
▲ 2.77% since 12 Oct, 6:15 pm
5.54.22.812 Oct, 6:15 pm12 Oct, 7:15 pm

3 archived readings. Marketframe stores its own observations; readings before we began archiving cannot be backfilled.

Subscription

No archived readings yet. Marketframe stores a reading every 15 minutes while an issue is live.

GMP premium54/100

5.54% unofficial premium

Subscription—

Subscription unavailable

Institutional (QIB) bids—

Not published yet

Valuation vs peers—

Not in the RHP notes yet

Profit trend—

Not in the RHP notes yet

Where the money goes—

Offer split unavailable

Balance sheet—

Not in the RHP notes yet

Promoter holding—

Not in the RHP notes yet

Sector track record—

Sector not set yet

FUSION CX LIMITED IPO — COMMON QUESTIONSUPDATED LIVE
What is the GMP of Fusion CX Limited today?

The latest unofficial grey market premium for Fusion CX Limited is ₹55 (5.54% of the upper price band), sourced from InvestorGain. GMP is unofficial and unregulated.

What is the price band of Fusion CX Limited?

The price band is ₹275–₹289 per share, as filed with NSE.

When does Fusion CX Limited open and close?

The issue window is 14–16 Oct 2026. The current status is upcoming.

How much is Fusion CX Limited subscribed?

Live subscription figures are published by NSE once bidding opens.

Is Fusion CX Limited a good IPO to apply for?

Marketframe does not publish apply or avoid calls. The Marketframe score combines market demand (GMP, subscription, institutional bids) with facts from the offer document (valuation against listed peers, profit trend, fresh issue vs OFS, debt, promoter holding and sector record). It is an automated summary of data, not a recommendation or investment advice. Read the RHP and consult a SEBI-registered adviser.

VERIFIED NOW

↑Issue schedule verified from NSE

↑Price band published

CHECK BEFORE APPLYING

!GMP is unofficial and not verified by NSE

!Read the RHP risk factors before applying

OTHER UPCOMING IPOSLIVE BOARD

Schedule, price band and live subscription data are sourced from NSE India. *GMP is sourced from InvestorGain, is unofficial and unregulated. The Marketframe score summarises market demand and offer-document data; it does not predict listing gains or returns. Marketframe does not provide investment advice. Verify every decision using SEBI, NSE, BSE and the relevant offer document.